INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $232,000 | +3.6% | 33,468 | +39.2% | 0.00% | – |
| Q3 2016 | $224,000 | +5.2% | 24,044 | +4.2% | 0.00% | – |
| Q2 2016 | $213,000 | +10.9% | 23,081 | +4.6% | 0.00% | – |
| Q1 2016 | $192,000 | +123.3% | 22,064 | +71.1% | 0.00% | – |
| Q4 2015 | $86,000 | +11.7% | 12,896 | -3.2% | 0.00% | – |
| Q3 2015 | $77,000 | -4.9% | 13,325 | +34.3% | 0.00% | – |
| Q2 2015 | $81,000 | +37.3% | 9,925 | +36.9% | 0.00% | – |
| Q1 2015 | $59,000 | +37.2% | 7,250 | +54.8% | 0.00% | – |
| Q4 2014 | $43,000 | -97.2% | 4,682 | -96.7% | 0.00% | -100.0% |
| Q2 2014 | $1,512,000 | – | 139,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |